Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Brand Name
Calcium Polycarbophil
Generic Name
Calcium Polycarbophil
Active Ingredient
Calcium PolycarbophilCategory
Other
Variants
4
Different strengths and dosage forms
| Strength | Form | Route | NDC |
|---|---|---|---|
| 625 mg/1 | TABLET, FILM COATED | ORAL | 69842-846 |
| 625 mg/1 | TABLET, FILM COATED | ORAL | 70000-0067 |
| 625 mg/1 | TABLET, FILM COATED | ORAL |
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Calcium Polycarbophil, you must consult a qualified healthcare professional.
| 625 mg/1 | TABLET | ORAL | 70369-006 |
Detailed information about Calcium Polycarbophil
Calcium Polycarbophil is a synthetic, bulk-forming laxative and antidiarrheal agent used to treat constipation and symptoms of irritable bowel syndrome (IBS). It works by absorbing water in the intestinal tract to create softer, bulkier stools that are easier to pass.
For the treatment of constipation or diarrhea in adults and adolescents 12 years of age and older, the standard dosage of Calcium Polycarbophil is typically 1,250 mg (usually two 625 mg caplets) taken one to four times daily.
Calcium Polycarbophil should be used in children only under the guidance of a pediatrician.
Patients with significant renal (kidney) impairment or those with a history of kidney stones (nephrolithiasis) should exercise caution. While the absorption of calcium from this product is low, the cumulative effect in patients with reduced clearance may lead to hypercalcemia (high blood calcium levels).
No specific dosage adjustments are required for patients with liver disease, as the drug is not metabolized by the liver and does not enter systemic circulation.
Geriatric patients are at a higher risk for dehydration and fecal impaction. It is critical that elderly users consume adequate fluids. Lower starting doses may be appropriate to assess tolerance.
To ensure safety and efficacy, Calcium Polycarbophil must be taken correctly:
If you miss a dose of Calcium Polycarbophil, take it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed dose and resume your regular schedule. Do not double the dose to catch up.
Signs of a Calcium Polycarbophil overdose are primarily gastrointestinal and may include severe abdominal cramping, bloating, and potentially a bowel obstruction if taken without sufficient water. If an overdose is suspected, or if the patient experiences severe abdominal pain or inability to pass stool, seek emergency medical attention or contact a poison control center immediately.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance. If symptoms of constipation persist for more than 7 days, or if rectal bleeding occurs, discontinue use and consult a doctor.
Because Calcium Polycarbophil is not absorbed into the body, its side effects are almost exclusively localized to the gastrointestinal tract. Most common effects are mild and often resolve as the body adjusts to the increased fiber intake.
Calcium Polycarbophil is an effective therapeutic agent, but it must be used with caution in specific clinical scenarios. The most critical safety factor is the mandatory intake of at least 8 ounces of fluid with every dose. Failure to do so not only renders the medication ineffective but also poses a significant risk of physical obstruction in the upper digestive tract.
There are no FDA black box warnings for Calcium Polycarbophil. It is categorized as a safe and effective OTC bulk-forming laxative when used according to label directions.
While there are no absolute contraindications with other drugs that result in fatal outcomes, Calcium Polycarbophil should not be taken simultaneously with certain medications due to the risk of treatment failure.
Calcium Polycarbophil must NEVER be used in the following circumstances:
Calcium Polycarbophil is generally considered safe for use during pregnancy and is often a preferred choice for pregnancy-induced constipation. It is not absorbed systemically, meaning there is no direct exposure to the developing fetus.
Calcium Polycarbophil does not pass into breast milk because it is not absorbed into the mother's bloodstream. It is considered safe for use by nursing mothers. No adverse effects have been observed in nursing infants whose mothers were taking the medication.
Calcium Polycarbophil is a synthetic, high-molecular-weight polymer of acrylic acid cross-linked with divinyl glycol. Its primary pharmacological action is hydrophilic adsorption.
In the stomach, the calcium ions dissociate from the polycarbophil molecule in the presence of gastric acid. The resulting polycarbophil molecule is a powerful hydrophilic agent. As it enters the neutral-to-alkaline environment of the small intestine and colon, the polymer chains expand and create a gel-like matrix. This matrix binds water molecules through hydrogen bonding.
Common questions about Calcium Polycarbophil
Calcium Polycarbophil is a versatile medication used primarily to treat constipation and to restore bowel regularity. It is also uniquely effective for managing the symptoms of Irritable Bowel Syndrome (IBS) because it can stabilize stool consistency for both constipation and diarrhea. By acting as a bulk-forming agent, it absorbs water to soften hard stools or to firm up liquid stools. Healthcare providers often recommend it as a safer, non-habit-forming alternative to stimulant laxatives. It is commonly used by adults and children over the age of six who require a reliable fiber supplement.
The most common side effects of Calcium Polycarbophil are localized to the digestive system and include abdominal bloating, gas (flatulence), and mild stomach cramps. These symptoms usually occur when first starting the medication as the digestive tract adjusts to the increased bulk. Because the drug is not absorbed into the bloodstream, systemic side effects like dizziness or headaches are extremely rare. Most patients find that these minor gastrointestinal issues resolve within a few days of consistent use. To minimize these effects, it is recommended to start with a lower dose and increase it gradually while maintaining high water intake.
There is no known direct chemical interaction between alcohol and Calcium Polycarbophil that would cause a dangerous reaction. However, alcohol is a known diuretic, which means it can lead to dehydration by increasing urine output. Since Calcium Polycarbophil requires significant amounts of water to work safely and effectively, drinking alcohol can increase the risk of the medication causing a bowel obstruction or worsening constipation. If you choose to consume alcohol, it is vital to drink extra water to compensate for the dehydrating effects. Always consult your doctor about your alcohol consumption habits when taking any medication.
Calcium Polycarbophil is generally considered one of the safest options for treating constipation during pregnancy. Because the medication is a large polymer that is not absorbed into the bloodstream, it does not reach the developing fetus. Medical organizations like the American College of Obstetricians and Gynecologists (ACOG) often suggest bulk-forming laxatives as a first-line treatment for pregnancy-related digestive issues. It provides a gentle way to manage bowel changes without the risks associated with stimulant laxatives. However, pregnant women should always consult their obstetrician before starting any new supplement to ensure it fits their specific health profile.
Calcium Polycarbophil is not an immediate-acting laxative and typically takes between 12 and 72 hours to produce a bowel movement. Its onset of action depends on several factors, including the individual's metabolic rate, their current level of hydration, and the severity of their constipation. For some patients, the full therapeutic benefit may not be realized until the medication has been taken consistently for two or three days. It is designed for gentle, predictable relief rather than the rapid, often urgent results seen with stimulant laxatives. If you do not see results after seven days of use, you should contact your healthcare provider.
Yes, you can stop taking Calcium Polycarbophil suddenly without experiencing physical withdrawal symptoms, as it is not a habit-forming drug. However, if you have been using it to manage chronic constipation, stopping abruptly may cause your symptoms to return. To maintain bowel regularity after discontinuation, it is often helpful to gradually increase your intake of high-fiber foods like fruits, vegetables, and whole grains. If you were taking it for a specific medical condition like IBS, consult your doctor before stopping. They may recommend a tapering schedule or alternative lifestyle modifications to ensure your digestive health remains stable.
If you miss a dose of Calcium Polycarbophil, you should take it as soon as you remember, provided it is not almost time for your next scheduled dose. If it is nearly time for the next dose, simply skip the missed one and continue with your regular routine. You should never take two doses at the same time to make up for a missed one, as this can increase the risk of bloating or intestinal discomfort. Since the medication works by building up bulk over time, a single missed dose is unlikely to significantly disrupt your progress. Consistency is key, so try to take your doses at the same time each day.
Calcium Polycarbophil does not cause true weight gain in the form of increased body fat because it contains no calories and is not absorbed by the body. Some users might notice a very slight, temporary increase in the number on the scale due to the water being held by the fiber in the intestinal tract. This is simply 'water weight' within the digestive system and is a sign that the medication is working correctly to bulk the stool. Conversely, by promoting regular bowel movements, some patients feel less 'heavy' or bloated. It is not a weight-loss product and should not be used for that purpose.
Calcium Polycarbophil can interact with several other medications, so timing is very important. Because it contains calcium, it can bind to certain drugs like tetracycline antibiotics, fluoroquinolones, and thyroid medications, preventing them from being absorbed. To avoid this, you should generally take other medications at least 2 hours before or 2 hours after taking Calcium Polycarbophil. Some medications may require an even longer gap, such as 4 to 6 hours. Always provide your pharmacist or doctor with a full list of your current medications and supplements to ensure there are no dangerous or counterproductive interactions.
Yes, Calcium Polycarbophil is widely available as a generic medication and is also sold under various well-known brand names like FiberCon. The generic versions are required by the FDA to have the same active ingredient and provide the same therapeutic effect as the brand-name products. Generic versions are often more cost-effective for long-term management of chronic conditions. You can find these products in the digestive health aisle of most pharmacies and grocery stores. When purchasing a generic, always check the label to ensure the active ingredient is Calcium Polycarbophil 625 mg and that there are no added stimulants.
Other drugs with the same active ingredient (Calcium Polycarbophil)
> Warning: Stop taking Calcium Polycarbophil and call your doctor immediately if you experience any of these serious symptoms.
Calcium Polycarbophil is generally considered safe for long-term use under medical supervision; however, chronic reliance on any laxative can mask underlying medical issues. Long-term use without adequate hydration can lead to chronic constipation or the development of 'laxative lung' (lipid pneumonia), though this is more associated with mineral oil. The primary concern with long-term use of Calcium Polycarbophil is the potential for minor changes in mineral balance, specifically calcium levels, in susceptible individuals.
No FDA black box warnings currently exist for Calcium Polycarbophil. However, the FDA requires a specific 'Choking Warning' on the labeling of all bulk-forming laxatives. This warning emphasizes that taking the product without adequate fluid can cause it to swell and block the throat or esophagus, which may cause choking.
Report any unusual symptoms to your healthcare provider. Monitoring for changes in bowel habits is essential for long-term safety.
For the average healthy user, routine lab monitoring is not required. However, for specific populations, the following may be monitored by a healthcare provider:
Calcium Polycarbophil does not cross the blood-brain barrier and has no known sedative or psychoactive effects. It is considered safe to drive or operate machinery while using this medication.
There are no direct chemical interactions between alcohol and Calcium Polycarbophil. However, alcohol can cause dehydration, which significantly increases the risk of side effects like constipation or impaction when taking bulk-forming fibers. It is recommended to limit alcohol and increase water intake.
There is no physical withdrawal syndrome associated with Calcium Polycarbophil. However, stopping the medication abruptly after long-term use may result in a return of constipation symptoms. It is often best to gradually increase natural dietary fiber intake while tapering off the supplement.
> Important: Discuss all your medical conditions, especially any history of stomach or intestinal problems, with your healthcare provider before starting Calcium Polycarbophil.
Calcium Polycarbophil does not typically interfere with most common blood or urine tests. However, it may affect the results of:
For each major interaction, the mechanism is usually chelation or physical adsorption. To manage these, the standard strategy is temporal separation—ensuring that other medications are taken at least 2 hours before or 2-4 hours after the Calcium Polycarbophil dose.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including other laxatives or stool softeners.
Conditions requiring a careful risk-benefit analysis by a physician:
There is no known cross-sensitivity between Calcium Polycarbophil and other fiber types like psyllium, methylcellulose, or wheat dextrin. However, patients who have had allergic reactions to other polyacrylic acid polymers (used in some topical gels or other medications) should use Calcium Polycarbophil with caution.
> Important: Your healthcare provider will evaluate your complete medical history, including any history of 'megacolon' or intestinal narrowing, before prescribing Calcium Polycarbophil.
Elderly patients are the primary users of this medication but also the most vulnerable to its risks.
In patients with a GFR (Glomerular Filtration Rate) below 30 mL/min, the calcium load from the medication (approximately 100-150 mg of absorbable calcium per dose) must be accounted for in the total daily mineral intake to prevent hypercalcemia or renal calculi (kidney stones).
No adjustments are needed for patients with Child-Pugh Class A, B, or C cirrhosis, as the drug's action is purely intraluminal and does not involve hepatic processing.
> Important: Special populations, particularly the elderly and those with kidney disease, require individualized medical assessment to determine the safest fiber source.
| Parameter | Value |
|---|---|
| Bioavailability | 0% (Polymer is not absorbed) |
| Protein Binding | N/A |
| Half-life | N/A (Dependent on GI transit time) |
| Tmax | N/A (No peak plasma concentration) |
| Metabolism | None |
| Excretion | Fecal (100% as unchanged polymer) |
Calcium Polycarbophil is classified as a Bulk-Forming Laxative. It is grouped with other agents such as Psyllium husk, Methylcellulose, and Wheat Dextrin. It is distinguished from 'Stimulant Laxatives' (like Senna or Bisacodyl) and 'Osmotic Laxatives' (like Polyethylene Glycol or Magnesium Citrate) by its mechanical, fiber-like action.